Janssen (United States)

Janssen (United States)

Johnson & Johnson Innovative Medicine is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen, Founder of Fentanyl. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Janssen (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

59%


Total
Publications

11K


Total Open
Publications

6.5K


Total
Citations

343K


Open Access
Percentage

59%


Total
Publications

11K


Total Open
Publications

6.5K


Total
Citations

343K

Wikipedia

Website

download

Breakdown

24% 28% 7% 41%

Publisher Open

24%

Both

28%

Other Platform Open

7%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

01002003004005006007008009001k1.1k1.2kTotal Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

32%OA Journal

OA Journal 32%

1.8K

Hybrid 40%

2.3K

No Guarantees 28%

1.6K

Other Platform Open

Domain 84%

3.3K

Institution 25%

985

Other Internet 12%

452

Public 9%

339

Preprint 8%

321

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
3.3K
Europe PMC
Domain
1.4K
DOI
Other Internet
426
University College London - UCL Discovery
Institution
204
Semantic Scholar
Public
199
Figshare
Public
195
Erasmus University Rotterdam - EUR Research Repository
Institution
165
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
150
California Digital Library - eScholarship
Other Internet
124
University of California - eScholarship University of California
Institution
117
1 / 20

Data updated 7 April 2025

Share

Share

Share